Sevoflurane Preconditioning Mitigates Hypoxia and Reoxygenation Injury in Cardiomyocytes Through microRNA ‐451a Regulation
APMIS · 2026-01 · 134 (1)
DOI: 10.1111/apm.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, online erschienen am 08.01.2026. Verfasst von Qiang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Sevoflurane, Myocytes, Cardiac, Methyl Ethers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
This study investigated whether Sevoflurane preconditioning (Sevo‐pre) attenuates hypoxia/reoxygenation (H/R)‐triggered myocardial damage by targeting microRNA‐451a (miR‐451a) and its downstream target interleukin 6 receptor (IL6R). Rat embryonic cardiomyoblast‐derived H9C2 underwent H/R injury modeling with either Sevo‐pre or no preconditioning. Mechanistic studies employed the manipulation of miR‐451a overexpression and silencing, alongside IL6R modulation via targeted siRNA and plasmid transfection. Sevo‐pre significantly enhanced cell viability, reduced apoptosis, and decreased injury markers in H/R‐induced cells ( p < 0.001). Notably, miR‐451a was downregulated in H/R conditions but upregulated by Sevo‐pre. The inhibition of miR‐451a negated Sevo's protective effects, exacerbating oxidative stress and apoptosis ( p < 0.001). Bioinformatics analyses and luciferase assays identified IL6R as a direct target of miR‐451a. Silencing IL6R mitigated the adverse effects of miR‐451a inhibition, restoring cell viability and reducing oxidative stress ( p < 0.001). Sevo‐pre alleviates H/R injury in cardiomyocytes through the regulation of miR‐451a, which suppresses IL6R expression, consequently reducing oxidative stress and apoptosis. This study elucidates a novel cardioprotective mechanism of preconditioning via the miR‐451a/IL6R axis, which highlights miR‐451a and IL6R as potential therapeutic targets for mitigating myocardial I/R injury in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Jinping Li
Zitieren
APA
Li, Q., Shi, X., Li, J., & Chen, Y. (2026). Sevoflurane Preconditioning Mitigates Hypoxia and Reoxygenation Injury in Cardiomyocytes Through microRNA ‐451a Regulation. APMIS, 134(1). https://doi.org/10.1111/apm.70127
Vancouver
Li Q, Shi X, Li J, Chen Y. Sevoflurane Preconditioning Mitigates Hypoxia and Reoxygenation Injury in Cardiomyocytes Through microRNA ‐451a Regulation. APMIS. 2026;134(1). doi:10.1111/apm.70127
BibTeX
@article{Li2026,
author = {Li, Qiang and Shi, Xibao and Li, Jinping and Chen, Ying},
title = {Sevoflurane Preconditioning Mitigates Hypoxia and Reoxygenation Injury in Cardiomyocytes Through microRNA ‐451a Regulation},
journal = {APMIS},
year = {2026},
volume = {134},
number = {1},
doi = {10.1111/apm.70127}
}
EUVIMED